Lupin acquires Boehringer Ingelheim's brands Ondero and Ondero Met to expand diabetes portfolio in India
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Need to harmonize traditional and modern medicine to combat alarming health problems
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
The inspection was conducted from August 7 to August 11, 2023 and concluded without any observations.
IOL Chemicals and Pharmaceuticals has reported total income of Rs. 570.24 crores during the period ended June 30, 2023
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes
Medica Superspecialty Hospital becomes the first private hospital in Eastern India to collaborate with UNICEF for breastfeeding workshop
Subscribe To Our Newsletter & Stay Updated